KS

Kongkona Saikia

Active Director Designated Partner DIN 10210514
DIN 10210514 First appointment Jun 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kongkona Saikia

Data last updated:

Kongkona Saikia is a Designated Partner at Karpagam Antibody Production Llp (since 2023) and Designated Partner at Karpagam Drug Delivery System Llp (since 2023). The companies operate in Paper.

DIN 10210514
Primary Designation Designated Partner
Industry Paper
First Appointment 22 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Jul 20232023Active
Designated Partner22 Jun 20232023Active

Board colleagues of Kongkona Saikia

Directorship timeline

Open interactive timeline →
Karpagam Antibody Production Llp
Karpagam Drug Delivery System Llp
Premium access

Shareholding and investment profile for Kongkona Saikia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kongkona Saikia

Kongkona Saikia currently holds 2 directorships: Karpagam Antibody Production Llp (Designated Partner, since 13 Jul 2023); Karpagam Drug Delivery System Llp (Designated Partner, since 22 Jun 2023).

Kongkona Saikia was first appointed on 22 Jun 2023 as Designated Partner at Karpagam Drug Delivery System Llp.

The current boards of Kongkona Saikia's companies include Muthusami Sridhar Muthusami (Karpagam Antibody Production Llp), Karanam Rathankumar Abiram (Karpagam Drug Delivery System Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available